logo_MedUX-alta-1

MedUX Insights

Unveiling #1 QoE Countries in Europe and Latam

Register here to receive a copy of our report

 

Register now

Beyond coverage maps and headline speeds, what matters is what people actually experience on the network—every day, in real conditions.

In the 5G era, it’s not enough to be “covered” or to headline peak speeds. What matters is what people actually experience every day: consistency, reliability, and real service performance. This report ranks countries using a single Mobile Experience Score that synthesizes true end-user QoE in real conditions.
Register now to download the report and be among the first to access the full ranking. At MWC26, we’ll reveal the leaders and close with an awards moment recognizing the top-performing countries.

What’s inside:

  • Country ranking across Europe and LATAM powered by one Experience Score

  • Use-case insights (e.g., streaming) to explain not only who leads, but why

  • Evidence designed for operators, regulators, and policy makers advancing meaningful connectivity

Register & download the report

MedUX is committed to recurring 5G benchmarking campaigns and is actively working towards enabling continuous, 24/7 QoE monitoring in select geographies on demand. If you are interested in exclusive insights or strategic collaborations, feel free to reach out to us at hello@medux.com.

In the meantime, we invite you to explore the details of our recent blog post and download a copy of our detailed report on the true 5G experience in Europe: “Unlocking the Power of the Crowd: MedUX’s Global QoE Crowdsourcing Solution

 

ALL RIGHTS RESERVED. This article or report has been prepared for the exclusive use and benefit of press media and solely for non-commercial purposes. Press media members are authorized to entirely or partially disseminate, refer, quote, copy, reproduce, distribute, publish and transfer the report and its findings (including all intellectual property rights, data, content graphs and analysis) for information purposes with express attribution to MedUX. Use of the report and its findings, entirely or partially, in any form or by any means, by any other third party or for any other purposes (including, commercial or marketing purposes), without the prior written consent of MedUX, is strictly prohibited. Operators can make a request to MedUX for a license to use quality or certification seals, as well as marketing rights to quote the findings. Non-authorized use will be considered a violation of copyright and trademarks laws.

www.medux.com